


IMMY Andrew R. Boll Insider Trades for Imprimis Pharmaceuticals Inc.


































Bulletin






Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Imprimis Pharmaceuticals Inc.

                  NASDAQ: IMMY
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Imprimis Pharmaceuticals Inc.



Market open
 --Real time quotes
Jul 26, 2017, 1:14 p.m.


IMMY

/quotes/zigman/14072651/composite


$
2.62




Change

-0.03
-1.13%

Volume
Volume 118,337
Real time quotes








/quotes/zigman/14072651/composite
Previous close

$
			2.65
		


$
				2.62
			
Change

-0.03
-1.13%





Day low
Day high
$2.55
$2.72










52 week low
52 week high

            $1.65
        

            $4.69
        


















Insider Activity


Individual




Andrew R. Boll



Mr. Andrew R. Boll is CFO, Secretary & Principal Accounting Officer at Imprimis Pharmaceuticals, Inc., a Member at CFA Institute, a Member at Cfa Society San Diego and a Member at Institute of Management Accountants, Inc. He received his undergraduate degree from Huron University.



Transactions


Date
Shares
Transaction
Value





12/19/2016
39,000


 
Acquisition at $1.79 per share.


69,810


02/01/2016
15,000


 
Derivative/Non-derivative trans. at $3.68 per share.


55,200


02/01/2015
30,000


 
Award at $0 per share.


0


02/01/2015
157,500


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. Robert J. Kammer 
Chairman




Mr. Mark L. Baum 
Chief Executive Office & Director




Mr. Clayton D. Edwards 
Chief Operating Officer




Mr. Andrew R. Boll 
CFO, Secretary & Principal Accounting Officer




Mr. John P. Saharek 
Chief Commercial Officer




Mr. Gary W. Seelhorst 
Vice President-Business Development




Ms. Bonnie  Ortega 
Director-Investor Relations




Mr. Anthony J. Principi 
Independent Director




Dr. Richard L. Lindstrom 
Independent Director




Mr. Stephen G. Austin 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/65801738/composite TLT+1.11%


/quotes/zigman/59386294/composite JNUG-5.94%


X




Powered by














Log In




1:17 PM EDT
July 26, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
1:17pTwitter earnings: Analysts fear that last quarter’s user increase won’t be repeated 
1:14pFuelCell shares halted for news
1:13pU.S. Steel surges 7% as better-than-expected earnings offset Trump comments
1:13pMichael Kors gets a toehold in men’s shoes with Jimmy Choo purchase
1:13pLVMH's profit climbs 24% in first half
1:11pDirecTV is proving good for AT&T’s wireless business, bad for TV
1:10pCoke Zero to be replaced in U.S. market with Coca-Cola Zero Sugar
1:08pThis is why it doesn’t make sense for an ex-Congressman to shame homeless people for smartphone use
1:03pUPDATE: Eagle Pharma stock plummets 21% on news that heat stroke drug failed to get FDA approval
12:55pBoeing shares soar to record after ‘close to perfect’ earnings report
12:53pFord’s quarterly beat not enough to lift beleaguered stock
12:52pU.S. stocks ride to records after strong earnings
12:49pYour 401(k) match may have some strings attached
12:49pThese companies spent over $1 billion buying back shares while their CEOs were dumping them
12:48pShares of AT&T are up more than 5%
12:46pBoeing's stock vaults past Goldman's to be the Dow's biggest driver
12:46pFoxconn to unveil plans for Wisconsin factory later Wednesday: Washington Post
12:43pWhy kids need to take personal finance classes in elementary school
12:43pMoney Milestones: How to manage your savings once you become a parent’s caregiver
12:37pCan I convert my RMD to a Roth IRA?
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,702.34

+88.91
+0.41%





nasdaq

/quotes/zigman/12633936/realtime
6,420.50

+8.33
+0.13%





s&p 500

/quotes/zigman/3870025/realtime
2,478.31

+1.18
+0.05%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Andrew R Boll - Carlsbad, CA | Intelius



























Sign In



We found Andrew R Boll in Carlsbad, CA


Andrew R Boll

                                                                           Intelius found that Andrew R Boll  is  a male between 30 and 40 years old from Carlsbad, CA.  We have connected them to
                14 addresses,
                3 phones,
                and 9 relatives or associates.
         






Get Report Now

Age

Andrew R Boll is in his 30s

Andrew Has Lived In

Carlsbad, CA
Huron, SD
Minneapolis, MN

Andrew's Relatives

Jennie Eicker
Francis Boll
Catherine Boll
Katie Boll







Andrew R Boll



Zodiac SignVirgo



GenderMale



Professional Status
Vice President - Accounting And Financial Reporting at Imprimis Pharmaceuticals, Inc.



Get Report Now










Want to know more about Andrew? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Andrew, or use our people search engine to find others.
Get Background Check on Andrew R Boll
Get a Criminal Check on Andrew R Boll
Get a Public Record Report on Andrew R Boll
Get a People Search Report on Andrew R Boll


Andrew R Boll's Contact Information
Known Cities Lived In
Find out where Andrew R Boll has lived as well as Andrew R Boll's phone numbers and email addresses.




Andrew R Boll Has Lived in 3 States
California Address for Andrew R Boll


1540 W******** R* 

Carlsbad, CA


Has Lived In

Carlsbad, CA
Huron, SD


Get Full Address Report










Phone Numbers Associated with Andrew R Boll

(651) ***-**** - Carlsbad, CA 
(858) ***-**** - Lake Forest, CA 
(605) ***-**** - Huron, SD 


Get Full Phone Report



Email Addresses Associated with Andrew R Boll

j********l@***.com
a***l@***.com


Get Email Report




Andrew R Boll's Professional Information
Information regarding Andrew R Boll's professional history.  Find out previous places Andrew R Boll has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Andrew R Boll Has Worked at 2 Places
Company: Imprimis Pharmaceuticals, Inc.
               Title: Vice President - Accounting And Financial Reporting
Company: Imprimis Pharmaceuticals, Inc.
               Title: Executive
Andrew R Boll's Experience
Title: Vice President - Accounting And Financial Reporting
               Company: Imprimis Pharmaceuticals, Inc.
Job Details
               Company Size: Less than $1 mil - Employee Range: Less than 25
Title: Executive
               Company: Imprimis Pharmaceuticals, Inc.
Job Details
               Company Size: $5 mil to less than $10 mil - Employee Range: 100 to less than 500
Additional Professional Information on Andrew R Boll

 See Andrew R Boll's LinkedIn Profile



Andrew R Boll's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Andrew R Boll


Andrew R Boll's known Social Networks And Potential Email Matches

Find all of Andrew R Boll's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Andrew Boll
Username Matches

                  AndrewBoll
                  BollAndrew
                  Andrew.Boll
                  Boll.Andrew
                  Andrew_Boll
                  Boll_Andrew
                  Andrew-Boll
                  Boll-Andrew
                  ABoll
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
A Boll







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.






















 



















































Andrew R. Boll - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Andrew R. Boll
Chief Financial Officer and Corporate Secretary at Imprimis Pharmaceuticals, Inc.


View Full Profile
Are you Andrew R. Boll? Claim your profile


 


Sign up for Equilar Atlas and view Andrew R. Boll's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Andrew R. Boll's  network and community.
												FOLLOW changes in Andrew R. Boll's employment and money-in-motion.
												CONNECT with Andrew R. Boll through your network of contacts.
												








Andrew R. Boll's Executive Work History


Current


Chief Financial Officer and Corporate Secretary, 
Imprimis Pharmaceuticals, Inc.


Past
To view Andrew R. Boll's complete executive work history, sign up now
Education


														 B.S., 
															Si Tanka University-Huron Campus


Age
34

 
 


Andrew R. Boll's Biography



Andrew R. Boll, CFA, CMA started with Imprimis in December 2011, and has served as Imprimis' Chief Financial Officer since his promotion to that role in February 2015. He oversees the Company's accounting and financial reporting, investor relations, human resources and other operational departments. In December 2011, Mr. Boll worked as a consultant for Imprimis and was hired as its Vice President of Accounting and Public Reporting (Principal Financial and Accounting Officer) in February 2012. Prior to his start at Imprimis, from November 2007 to November 2011, Mr. Boll worked for BCGU, LLC, a privately held fund manager specializing in micro- ...
(Read More)

			Andrew R. Boll, CFA, CMA started with Imprimis in December 2011, and has served as Imprimis' Chief Financial Officer since his promotion to that role in February 2015. He oversees the Company's accounting and financial reporting, investor relations, human resources and other operational departments. In December 2011, Mr. Boll worked as a consultant for Imprimis and was hired as its Vice President of Accounting and Public Reporting (Principal Financial and Accounting Officer) in February 2012. Prior to his start at Imprimis, from November 2007 to November 2011, Mr. Boll worked for BCGU, LLC, a privately held fund manager specializing in micro-cap, small-cap and venture type investment opportunities. There he provided financial and accounting consulting services to public and private company clients. From 2004 to 2007, Mr. Boll held various accounting roles at Welsh Companies, LLC, a privately held commercial real estate company, its fund and its other subsidiaries. Mr. Boll is a CFA charterholder, Certified Management Accountant and earned his Bachelor of Science degree in Corporate and Public Finance. He is a member of the Institute of Management Accountants, the CFA Institute, and the CFA Society of San Diego.
		
Source: Imprimis Pharmaceuticals, Inc. on 04/27/2017
		
	

 






Sign up for Equilar Atlas and view Andrew R. Boll's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Andrew R. Boll. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Andrew R. Boll's  network and community.
												FOLLOW changes in Andrew R. Boll's employment and money-in-motion.
												CONNECT with Andrew R. Boll through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Andrew R. Boll


















Andrew R. Boll's Connections (12)





Sign up now to view Andrew R. Boll's 12 connections »









William H. Nelson
Former Board Member, Imprimis Pharmaceuticals, Inc.









Peter C. Kenny
Lead Independent Director, Bank of the Ozarks, Inc.









Robert J. Kammer
Chairman of the Board, Imprimis Pharmaceuticals, Inc.









Anthony J. Principi
Board Member, Imprimis Pharmaceuticals, Inc.









Mark L. Baum
Dir. and Chief Executive Officer, Imprimis Pharmaceuticals, Inc.









Stephen G. Austin
Board Member, Imprimis Pharmaceuticals, Inc.









Joachim P. Schupp
Former Chief Medical Officer, Imprimis Pharmaceuticals, Inc.









August S. Bassani
Former Board Member, Imprimis Pharmaceuticals, Inc.









John P. Saharek
Chief Commercial Officer, Imprimis Pharmaceuticals, Inc.









Jeffrey J. Abrams
Former Board Member, Imprimis Pharmaceuticals, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









David J. O'Connor
President and CEO, The Madison Square Garden Company









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993

















Insider trading history of Boll Andrew R.    at Transdel Pharmaceuticals Inc 



















Insider Monitor



Realtime

Insider Buys 

Insider buys today     
Insider buys 1 day ago
Insider buys 2 days ago
Insider buys 3 days ago
Insider buys 4 days ago
Insider buys 5 days ago
Insider buys 6 days ago
Insider buys 7 days ago
Insider buys 8 days ago
Insider buys 9 days ago
Insider buys 10 days ago



Insider Sales 

Insider sales today       
Insider sales 1 day ago
Insider sales 2 days ago
Insider sales 3 days ago
Insider sales 4 days ago
Insider sales 5 days ago
Insider sales 6 days ago
Insider sales 7 days ago



Top 10 

Top 10 insider buys of the week
Top 10 officer buys of the week
Top 10 insider buys of the month
Top 10 officer buys of the month
Top 10 insider sales of the week
Top 10 insider sales of the month









               
		







 Insider Stock Trading History of Boll Andrew R.  








The following table details the trading activities 
(stock purchases, stock sales, and stock option exercises) 
reported to 
the Securities and Exchange Commission (SEC) 
by insider Boll Andrew R.  since year 2005. 
The trader's CIK number is 1542150.
At the time of this reporting, Boll Andrew R.  is the Chief Financial Officer of Transdel Pharmaceuticals Inc . 
(stock ticker symbol TDLP.OB).
See this page for all insider trading activities at Transdel Pharmaceuticals Inc . 





Stock purchases, sales, and option exercises reported by insider Boll Andrew R.  since 2005.
  

   Trade Date   
 Symbol 
 Company Name (Issuer) 
 Trade Type 
     Shares   
     Price ($)
   Value ($) 

 2016-12-19  IMMY  Transdel Pharmaceuticals Inc   Buy  39,000  1.79  69,810 
 2016-02-01  IMMY  Transdel Pharmaceuticals Inc   Option Ex  15,000  3.68  55,200 


Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more  information regarding the trades made by Boll Andrew R.  
(Chief Financial Officer of Transdel Pharmaceuticals Inc  at the time of this reporting) see 

the Securities and Exchange Commission (SEC)  website.


















 



















Newest Insider Buys 
Insider Trading Resources 
Archive  
Privacy  
Contact  
2016,2017 Market Holidays 
Market Hours 






Tweet



 ©2017, insider-monitor.com. All rights reserved. 
 
















Insider Trading - Boll Andrew R. - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Boll Andrew R.





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-12-19Purchase
2016-12-214:03 pm
Imprimis Pharmaceuticals Inc.
IMMY
Boll Andrew R.Chief Financial Officer
39,000
$1.79
$69,810
54,000(Direct)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-19Purchase
2016-12-214:03 pm
2016-06-232019-12-23
Imprimis Pharmaceuticals Inc.
IMMY
Boll Andrew R.Chief Financial Officer
39,000
$0.125
54,000(Direct)
View


2016-04-25Option Award
2016-04-267:08 pm
2016-04-252021-04-25
Imprimis Pharmaceuticals Inc.
IMMY
Boll Andrew R.Chief Financial Officer
157,500
$0
157,500(Direct)
View


2016-04-25Disposition
2016-04-267:08 pm
2015-02-012016-04-25
Imprimis Pharmaceuticals Inc.
IMMY
Boll Andrew R.Chief Financial Officer
157,500
$0
157,500(Direct)
View


2016-04-01Option Award
2016-04-056:30 pm
N/A2026-04-01
Imprimis Pharmaceuticals Inc.
IMMY
Boll Andrew R.Chief Financial Officer
60,000
$3.95
60,000(Direct)
View


2016-02-01Exercise
2016-02-0306:02 am
N/AN/A
Imprimis Pharmaceuticals Inc.
IMMY
Boll Andrew R.Chief Financial Officer
15,000
$3.68
202,500(Direct)
View


2016-02-01Exercise
2016-02-0306:02 am
N/A2016-02-01
Imprimis Pharmaceuticals Inc.
IMMY
Boll Andrew R.Chief Financial Officer
15,000
$3.68
202,500(Direct)
View


2015-02-01Option Award
2015-02-026:45 pm
N/AN/A
Imprimis Pharmaceuticals Inc.
IMMY
Boll Andrew R.Chief Financial Officer
157,500
$0
187,500(Direct)
View


2015-02-01Option Award
2015-02-026:45 pm
N/AN/A
Imprimis Pharmaceuticals Inc.
IMMY
Boll Andrew R.Chief Financial Officer
30,000
$0
187,500(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Wed, 26 Jul 2017 12:17:26 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  










Andrew R. Boll











































Home
Search
Sign-In/Up
Contracts
Dictionary
Clauses
Companies
People

About
FAQ
Blog








Follow Andrew R. Boll contracts
Click to sign-up for email updates.

      Loading...
    





Home



Sample Contracts



By Executive


Andrew R. Boll


Andrew R. Boll

SEC Documents
Filings
Personal financials
Insider transactions
Previous Companies

Transdel Pharmaceuticals
(NASDAQ:IMMY)


Sample Contracts with Andrew R. Boll



Transdel Pharmaceuticals –
Asset Purchase and License Agreement
(June 20th, 2017)
THIS ASSET PURCHASE AND LICENSE AGREEMENT (this "Agreement") dated as of May 9, 2017 (the "Effective Date"), is entered into between IMPRIMIS PHARMACEUTICALS, INC., a Delaware corporation ("Imprimis"), with a place of business at 12264 El Camino Real, Suite 350, San Diego, California 92130, and Eton Pharmaceuticals, Inc., a Delaware corporation ("Eton"), with a place of business at 12264 El Camino Real, Suite 350, San Diego, California 92130. The parties hereby agree as follows:



Transdel Pharmaceuticals –
Management Services Agreement
(June 20th, 2017)
THIS MANAGEMENT SERVICES AGREEMENT (this "Agreement"), effective as of the last date provided on the signature page (the "Effective Date"), is made by and between Eton Pharmaceuticals, Inc., a Delaware corporation (the "Company") and Imprimis Pharmaceuticals, Inc., a Delaware corporation (the "Manager").



Transdel Pharmaceuticals –
Asset Purchase and License Agreement
(June 20th, 2017)
THIS ASSET PURCHASE AND LICENSE AGREEMENT (this "Agreement") dated as of May 9, 2017 (the "Effective Date"), is entered into between IMPRIMIS PHARMACEUTICALS, INC., a Delaware corporation ("Imprimis"), with a place of business at 12264 El Camino Real, Suite 350, San Diego, California 92130, and Eton Pharmaceuticals, Inc., a Delaware corporation ("Eton"), with a place of business at 12264 El Camino Real, Suite 350, San Diego, California 92130. The parties hereby agree as follows:



Transdel Pharmaceuticals –
Stock Purchase Agreement
(February 17th, 2017)
THIS STOCK PURCHASE AGREEMENT (this "Agreement"), dated as of the last date provided for on the signature page herein (the "Effective Date"), is entered into by and among Imprimis Pharmaceuticals, Inc., a Delaware corporation (the "Seller"), ImprimisRx TX, Inc., a Texas corporation (the "Company") and Livernois & London, LLC, a Texas limited liability company (the "Buyer"). Each of the foregoing may be referred to herein as a "Party" and collectively as the "Parties."



Transdel Pharmaceuticals –
Third Amendment to Loan and Security Agreement
(December 29th, 2016)
THIS THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (this "Amendment"), dated as of December 27, 2016 (the "Amendment Effective Date"), is made among Imprimis Pharmaceuticals, Inc., a Delaware corporation (the "Borrower"), the undersigned Subsidiaries of the Borrower, in their capacities as Guarantors, IMMY Funding LLC, a Delaware limited liability company ("IMMY Funding LLC"), in its capacity as collateral agent (in such capacity, "Collateral Agent") and the Lenders listed on Schedule 1.1 (as amended herein) of the Loan and Security Agreement (as defined below) or otherwise a party hereto from time to time including IMMY Funding LLC in its capacity as a Lender (each a "Lender" and collectively, the "Lenders").



Transdel Pharmaceuticals –
Amendment No. 2 to Warrant to Purchase Stock
(December 29th, 2016)
This Amendment No. 2 to Warrant to Purchase Stock (this "Amendment"), dated as of December 27, 2016, is being entered into between Imprimis Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and IMMY Funding LLC, a Delaware limited liability company ("IMMY Funding"). Capitalized terms used in this Amendment without definition have the respective definitions ascribed to them in the Existing Warrant (as defined below).



Transdel Pharmaceuticals –
Exchange and Discharge Agreement
(December 29th, 2016)
This Exchange and Discharge Agreement (this "Agreement"), dated as of December 27, 2016, is being entered into between Imprimis Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and IMMY Funding LLC, a Delaware limited liability company ("IMMY Funding").



Transdel Pharmaceuticals –
Commercial Lease Agreement
(August 11th, 2016)
LESSOR:           CO-LESSEE:      ESSEX CAPITAL CORPORATION           IMPRIMIS PHARMACEUTICALS, INC.      1486 EAST VALLEY ROAD           12664 EL CAMINO REAL, SUITE 350      SANTA BARBARA, CA 93108           SAN DIEGO, CA 92130      EMAIL:  ralph@essexcapitalcorp.com           EMAIL:  aboll@imprimispharma.com



Transdel Pharmaceuticals –
Imprimis Pharmaceuticals, Inc. Employment Agreement
(April 26th, 2016)
This Employment Agreement (the "Agreement"), is made and entered into as of April 25, 2016, by and between Andrew R. Boll ("Executive") and Imprimis Pharmaceuticals, Inc. (the "Company").



Transdel Pharmaceuticals –
Imprimis Pharmaceuticals, Inc. Amended and Restated 2007 Incentive Stock and
Awards Plan Performance Stock Units Agreement
(April 26th, 2016)
Effective as of April 25, 2016 (the "Grant Date"), Imprimis Pharmaceuticals, Inc., a Delaware corporation (the "Company"), has awarded to Andrew R. Boll ("Grantee") a targeted number of 157,500 Performance Stock Units (the "Performance Stock Units" or "Award") to be calculated and determined as discussed below. Each Performance Stock Unit will represent an unfunded and unsecured promise of the Company to deliver shares of common stock, par value $0.01 per share, of the Company (the "Shares") to Grantee as set forth herein. Each Performance Stock Unit will be subject to forfeiture until the date such Performance Stock Unit vests pursuant to Section 1 of this Performance Stock Units Agreement (this "Agreement"). The Performance Stock Units have been granted pursuant to the Imprimis Pharmaceuticals, Inc. Amended and Restated 2007 Incentive Stock and Awards Plan (the "Plan"), and shall be subject to all provisions of the Plan, which are incorporated herein by reference, and of this Agreeme



Transdel Pharmaceuticals –
April 25, 2016 C/O Imprimis Pharmaceuticals, Inc. 12264 El Camino Real, Suite
350 San Diego, CA 92130 Dear Andrew,
(April 26th, 2016)
Imprimis Pharmaceuticals, Inc. (the "Company") is pleased to offer you the opportunity to earn a cash retention bonus (the "Retention Bonus") on the terms set forth in this letter (the "Letter"). We are offering you the opportunity to earn the Retention Bonus because we recognize your importance to the continued success of the Company and to the successful closing of a "Change in Control" (as defined below) of the Company. Subject to your execution, this Letter shall become effective as of the date set forth above (the "Effective Date").



Transdel Pharmaceuticals –
[Imprimis Letterhead]
(August 5th, 2015)
Imprimis Pharmaceuticals, Inc. (the "Company") is pleased to offer you the opportunity to earn a cash retention bonus (the "Retention Bonus") on the terms set forth in this letter (the "Letter"). We are offering you the opportunity to earn the Retention Bonus because we recognize your importance to the continued success of the Company and to the successful closing of a "Change in Control" (as defined below) of the Company.



Transdel Pharmaceuticals –
First Amendment to Amended and Restated Employment Agreement
(August 5th, 2015)
This First Amendment (the or this "Amendment") to the Amended and Restated Employment Agreement by and between Imprimis Pharmaceuticals, Inc. (the "Company"), a Delaware corporation, and Mark Baum (the "Executive"), is entered into as of July 31, 2015. Unless otherwise specified, capitalized terms not defined herein have the meaning set forth in the Employment Agreement (as defined below).



Transdel Pharmaceuticals –
Loan and Security Agreement
(May 12th, 2015)
THIS LOAN AND SECURITY AGREEMENT (as the same may be amended, restated, modified, or supplemented from time to time, this "Agreement") dated as of May 11, 2015 (the "Effective Date") among IMMY Funding LLC, a Delaware limited liability company, as collateral agent (in such capacity, together with its successors and assigns in such capacity, "Collateral Agent"), and the Lenders listed on Schedule 1.1 hereof or otherwise a party hereto from time to time including IMMY Funding LLC in its capacity as a Lender (each a "Lender" and collectively, the "Lenders"), and Imprimis Pharmaceuticals, Inc., a Delaware corporation ("Borrower"), provides the terms on which the Lenders shall lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows:



Transdel Pharmaceuticals –
Imprimis Pharmaceuticals, Inc. Amended and Restated 2007 Incentive Stock and
Awards Plan Performance Stock Units Agreement
(February 2nd, 2015)
Effective as of February 1, 2015 (the "Grant Date"), Imprimis Pharmaceuticals, Inc., a Delaware corporation (the "Company"), has awarded to Andrew R. Boll ("Grantee") a targeted number of 157,500 Performance Stock Units (the "Performance Stock Units" or "Award") to be calculated and determined as discussed below. Each Performance Stock Unit will represent an unfunded and unsecured promise of the Company to deliver shares of common stock, par value $0.01 per share, of the Company (the "Shares") to Grantee as set forth herein. Each Performance Stock Unit will be subject to forfeiture until the date such Performance Stock Unit vests pursuant to Section 1 of this Performance Stock Units Agreement (this "Agreement"). The Performance Stock Units have been granted pursuant to the Imprimis Pharmaceuticals, Inc. Amended and Restated 2007 Incentive Stock and Awards Plan (the "Plan"), and shall be subject to all provisions of the Plan, which are incorporated herein by reference, and of this Agree



Transdel Pharmaceuticals –
Imprimis Pharmaceuticals, Inc. Amended and Restated Employment Agreement
(February 2nd, 2015)
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the "Agreement") is entered into effective as of February 1, 2015 (the "Effective Date"), by and between Imprimis Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Andrew R. Boll ("Executive"), with respect to the following facts:





Follow Andrew R. Boll contracts
Click to sign-up for email updates.

      Loading...
    












×









      Have an account? Sign in here.

Law Insider
Recover your password







No account? Register Now!


No account? Register Now!
Sign in
by using one of this services











or







Forgot your password?


Have an account? Sign in here.
Join Law Insider
for Free
by using one of this services











or







By registering you agree to our
      terms of service.










Contract and Agreement Category List











































Home
Search
Sign-In/Up
Contracts
Dictionary
Clauses
Companies
People

About
FAQ
Blog







Sample Contract Categories 

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o

p

q

r

s

t

u

v

w

x

y

z


abcdefghijklmnopqrstuvwxyz


337k
		Delaware
	

277k
		New York
	

113k
		California
	

70k
		Texas
	

68k
		Agreement
	

62k
		Nevada
	

46k
		Florida
	

44k
		Maryland
	

40k
		Illinois
	

38k
		Employment Agreement
	

38k
		Washington
	

37k
		Amended And Restated
	

36k
		Massachusetts
	

34k
		New Jersey
	

33k
		Pennsylvania
	

28k
		Georgia
	

28k
		Colorado
	

26k
		Ohio
	

25k
		Minnesota
	

25k
		Virginia
	

21k
		North Carolina
	

20k
		Incentive Plan
	

19k
		Credit Agreement
	

19k
		Amendment
	

16k
		Connecticut
	

16k
		Michigan
	

15k
		Indiana
	

14k
		Registration Rights Agreement
	

14k
		Recitals
	

13k
		Tennessee
	

13k
		Arizona
	

13k
		Missouri
	

12k
		Purchase Agreement
	

12k
		Promissory Note
	

12k
		Indenture
	

11k
		Warrant
	

11k
		Louisiana
	

11k
		Kansas
	

11k
		Utah
	

11k
		Wisconsin
	

10k
		Oklahoma
	

9k
		Securities Purchase Agreement
	

9k
		Agreement And Plan Of Merger
	

8k
		Iowa
	

8k
		Supplemental Indenture
	

8k
		Note
	

8k
		Equity Incentive Plan
	

7k
		Kentucky
	

7k
		Stock Purchase Agreement
	

7k
		Alabama
	














×









      Have an account? Sign in here.

Law Insider
Recover your password







No account? Register Now!


No account? Register Now!
Sign in
by using one of this services











or







Forgot your password?


Have an account? Sign in here.
Join Law Insider
for Free
by using one of this services











or







By registering you agree to our
      terms of service.








    Andrew Boll | Imprimis Pharmaceuticals, Inc. | ZoomInfo.com
Imprimis Pharmaceuticals Inc (IMMY.O)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Imprimis Pharmaceuticals Inc (IMMY.O)










Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				IMMY.O on Consolidated Issue listed on NASDAQ Capital Market


				2.63USD
26 Jul 2017





				    Change	(% chg)


		    
						    $-0.02


					            (-0.62%)
					        






Prev Close

$2.65


Open

$2.70




Day's High

$2.71


Day's Low

$2.58




Volume

36,937


Avg. Vol

258,337




52-wk High

$4.69


52-wk Low

$1.65











					Summary





Name
Age
Since
Current Position




							Robert Kammer

64
2012

                                Chairman of the Board




							Mark Baum

42
2012

                                Chief Executive Officer, Director




							Andrew Boll

32
2015

                                Chief Financial Officer, Secretary




							Clayton Edwards

49
2017

                                Chief Operating Officer




							John Saharek

55
2015

                                Chief Commercial Officer




							Stephen Austin

62
2012

                                Independent Director




							Richard Lindstrom

69
2015

                                Independent Director




							Anthony Principi

72
2015

                                Independent Director



» Insider Trading





					Biographies





Name
Description




							Robert Kammer


					
							Dr. Robert J. Kammer, D.D.S., is Chairman of the Board of Imprimis Pharmaceuticals, Inc., since April 1, 2012. Dr. Kammer is a founder of our Company and has served as our director since December 2011 and as Chairman of the Board since April 2012. In June 2014, Dr. Kammer joined the board of directors of SoftScience Shoe Company as the co-chairman. In January 2015, Dr. Kammer retired from his clinical practice as a dentist, in which he was engaged from 1975 to 2015. He is a retired Diplomate of The American Board of Orofacial Pain and a Founding Member of The Academy for Sports Dentistry and Colorado Osseointegration Study Club. From 1979 to 1996, Dr. Kammer was an Associate Professor at the University of Colorado School of Dental Medicine. Dr. Kammer has also served as a consultant to the Boulder-Denver Pain Control Center and a reviewer for the Journal of Orofacial Pain. Dr. Kammer recently contributed a chapter to the text “Osteoperiosteal Flap”, has co-authored multiple scientific articles, was co-investigator on a Dental Implant Bar Study at the Mayo Institute from 2011 to 2013 and served as a consultant for Clear Choice Dental Implant Centers from 2010 to 2013. Dr. Kammer received his Bachelor of Science degree in 1971 from Xavier University, Cincinnati, Ohio. He received his Doctor of Dental Surgery degree from the University of Iowa College of Dentistry in 1974.




							Mark Baum


					
							Mr. Mark L. Baum J.D. is Chief Executive Officer, Director of Imprimis Pharmaceuticals, Inc. He is a founder of our Company, a director and our Chief Executive Officer. Beginning in 2011, Mr. Baum led the restructuring and reorganization of our Company, including our securities offerings to raise capital to support our business. Mr. Baum was appointed as a director of the Company in December 2011, served as the Chairman of the Board from December 2011 to April 2012, and was appointed as our Chief Executive Officer in April 2012. Prior to Mr. Baum’s involvement with our Company, from 2001 to 2011, he was the founder and managing director of TBLF, LLC, a law firm and fund manager, where he managed a series of three funds and acted as a principal investor in financing publicly traded companies or bridge-to-public equity transactions. Before his fund management experience, Mr. Baum founded and served as the president of YesRx, a publicly traded pharmacy business, and practiced as a U.S. securities lawyer focused on public company reporting requirements and finance-related matters. In addition, Mr. Baum serves on the board of directors for Ideal Power, Inc. (NASDAQ: IPWR),




							Andrew Boll


					
							Mr. Andrew R. Boll CFA is Chief Financial Officer, Secretary of Imprimis Pharmaceuticals, Inc.. He has been our Chief Financial Officer since February 2015 and previously served as the Company’s Vice President of Accounting and Financial Reporting since February 2012, overseeing the Company’s accounting and financial reporting, investor relations, human resources and other operational departments. Prior to that, Mr. Boll served as a consultant to the Company from December 2011 to February 2012. Mr. Boll has several years of experience in finance and accounting roles, including significant experience working with small capitalization companies and focusing on restructured and reorganized businesses. From November 2007 to November 2011, Mr. Boll worked for BCGU, LLC, a privately held fund manager specializing in capital venture type investment opportunities, and its related entities. There he provided financial and accounting consulting services to public and private company clients. From 2004 to 2007, Mr. Boll held various accounting roles at Welsh Companies, LLC, a privately held commercial real estate company, its fund and its other subsidiaries. Mr. Boll is a CFA charterholder, Certified Management Accountant and earned his B.S. degree in Corporate and Public Finance. He is a member of the Institute of Management Accountants, the CFA Institute, and the CFA Society of San Diego.




							Clayton Edwards


					
							Mr. Clayton D. Edwards is Chief Operating Officer of the Company. Mr. Edwards is a healthcare executive with over 30 years of experience developing and operationalizing complex healthcare products and services. Prior to joining Imprimis, he was the Senior Vice President of Home Delivery Pharmacy and Prior Authorization (June 2011 to June 2016) for OptumRx, a UnitedHealthcare company. He led an $18B P&L business segment, developing and improving Traditional and Specialty Pharmacy, Prior Authorization, financial infrastructure, enterprise-wide information technology and robotic systems, as well as overall productivity. Earlier in his career, he held various executive level positions at Doctor Diabetic Pharmacy/Sanare, Liberty Medical and Medco Health Solutions. He actively serves on the Albany College of Pharmacy & Health Sciences Dean’s Advisory Counsel, where he graduated with his Pharmacy degree. He also has a Master’s degree in Business Administration from St. Joseph’s University.




							John Saharek


					
							John P. Saharek is Chief Commercial Officer of Company. He has been our Chief Commercial Officer since February 2015 and previously served as the Company’s Vice President of Commercialization, Ophthalmology since November 2012. He is a senior healthcare industry executive with over 30 years of experience developing and commercializing pharmaceutical, biotech, surgical device and diagnostic product portfolios. His experience in these areas includes designing and executing strategic commercial plans, building brands, launching new products and holding leadership roles for a variety of healthcare companies. Over the past 15 years Mr. Saharek has been focused in the ophthalmology industry. Before joining the Company, he was the Head of U.S. Marketing and Strategy (April 2013 to October 2013) and National Director, Sales and Reimbursement (July 2011 to April 2013) for ThromboGenics Inc., a biotherapeutics company, where he worked on developing the commercial strategy and building a team to launch a new biologic into the U.S. market. Prior to that he was Vice President, Business Development at SurModics Inc., a provider of medical device coatings and in vitro diagnostic products, from March 2006 to July 2011, where he worked with large and small pharmaceutical companies on multi-platform drug delivery initiatives in the U.S. and internationally. Earlier in his career, he held positions in marketing and sales at a number of companies, including his tenure with Bausch & Lomb. Mr. Saharek has a Masters of Business Administration degree from the University of Hartford and a Bachelor’s degree from Central Connecticut State University.




							Stephen Austin


					
							Mr. Stephen G. Austin, CPA, is Independent Director of Imprimis Pharmaceuticals, Inc., since July 2012. He has served as our director since July 2012. He has been a Partner in Swenson Advisors, LLP, a regional accounting firm (registered with the Public Company Accounting Oversight Board), since May 1998 and has served as Managing Partner since October 2006. At Swenson Advisors, Mr. Austin manages assurance, Sarbanes-Oxley and other business consulting for public and private companies with a focus on technology, manufacturing, service, real estate, social media and non-profit organizations. Prior to joining Swenson Advisors, Mr. Austin accumulated over 22 years of experience as an audit partner with Price Waterhouse LLP, where he worked from 1976 to 1996, and with McGladrey & Pullen, LLP, where he worked from 1996 to 1998, serving both public and private companies. He serves as a board member or advisory board member for various not-for-profit foundations, associations and public service organizations in the United States, is on the global board of directors of Integra International, an international association of accounting firms, and served as a director on the board of Avanir Pharmaceuticals, Inc. (formerly NASDAQ: AVNR) from March 2003 to December 2012, where he also served on the audit committee and compensation committee. In 2004, Mr. Austin published a book on business ethics entitled “Rise of the New Ethics Class,” and in 2005 and 2006 he published articles in Asia discussing The Sarbanes-Oxley Act of 2002. Mr. Austin has also authored articles for the American Institute of CPAs, including the Journal of Accountancy. Mr. Austin holds a B.S. degree in accounting from Bob Jones University and an MBA degree from the University of Georgia and has been licensed as a Certified Public Accountant since 1978.




							Richard Lindstrom


					
							Dr. Richard L. Lindstrom, M.D., is Independent Director of the Imprimis Pharmaceuticals, Inc.. Dr. Lindstrom has served as our director since January 2015. Dr. Lindstrom is a founder, director and has been an attending surgeon at Minnesota Eye Consultants P.A., a provider of eye care services, since 1989. He has served as a researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon in the ophthalmology field. He has also served as a member of the board of directors of the following public companies: (i) TearLab Corporation (NASDAQ: TEAR) since 2010; (ii) Ocular Therapeutix, Inc. (NASDAQ: OCUL) since 2012; and (iii) OnPoint Medical Diagnostics, which merged with Vertical Health Solutions in 2011 (formerly OTCBB: ONMD), from 2010 to 2013. Dr. Lindstrom has also served as associate director of the Minnesota Lions Eye Bank since 1987 and he is a medical advisor for several medical device and pharmaceutical manufacturers and serves on the boards of several other privately-held life sciences companies. Dr. Lindstrom previously served as president of the International Society of Refractive Surgery from 1993 to 1994, the International Intraocular Implant Society from 2002 to 2004, the International Refractive Surgery Club from 2002 to 2004, and the American Society of Cataract and Refractive Surgery (“ASCRS”) from 2007 to 2008. Dr. Lindstrom currently serves on the ASCRS Executive Committee and is the Chair of the ASCRS Foundation. From 1980 to 1989, he served as a professor of ophthalmology at the University of Minnesota, where he is currently an adjunct professor emeritus. Dr. Lindstrom is also a board member of the University of Minnesota Foundation, chairing the Ophthalmology and Visual Neurosciences Division. Dr. Lindstrom holds a B.A. degree in Pre-Medical Studies, a B.S. degree in Medicine and an M.D. degree from the University of Minnesota.




							Anthony Principi


					
							Mr. Anthony J. Principi is Independent Director of Imprimis Pharmaceuticals, Inc. Mr. Principi served as Secretary, and during his tenure was responsible for a nationwide system of health care services, benefits programs and national cemeteries for America's 25 million veterans and dependents. Mr. Principi serves as CEO and president of The Principi Group, LLC, a consulting firm. In 2007, Mr. Principi joined the Wounded Warrior Project and was appointed to the position of Vice President in 2011 and served on the board until 2014. From 2005 through 2010, he was the Senior Vice President of Government Relations of Pfizer, Inc. Prior to joining Pfizer, Inc., Mr. Principi served as Secretary of the U.S. Department of Veterans Affairs from 2001 through 2005. In 2005, he served as the Chairman of the Defense 2005 Base Realignment and Closure Commission. Prior to becoming Secretary of the U.S. Department of Veterans Affairs, Mr. Principi was President of QTC Medical Services Inc. from 1999 through 2001 and Senior Vice President of Lockheed Martin IMS from 1995 through 1996. Prior to joining Lockheed Martin IMS, Mr. Principi was Chief Counsel and Staff Director of the U.S. Senate Armed Services Committee from 1993 through 1994, and was Chief Counsel and Staff Director of the U.S. Senate Committee on Veterans' Affairs from 1984 through 1988. Mr. Principi serves as a director of Mutual of Omaha. He is also a member of the board of directors of Engility Holdings, Inc., GetWellNetwork®, Inc. and Cleveland BioLabs, Inc. Mr. Principi served as Executive Chairman of QTC Management, and was a Director of Perot Systems Corporation. Mr. Principi received a Bachelor of Science from the U.S. Naval Academy and a Juris Doctor from Seton Hall University School of Law.











					Basic Compensation





Name
Fiscal Year Total




							Robert Kammer

--




							Mark Baum

633,954




							Andrew Boll

300,630




							Clayton Edwards

--




							John Saharek

--




							Stephen Austin

--




							Richard Lindstrom

--




							Anthony Principi

--



As Of 
30 Dec 2014





					Options Compensation





Name
Options
Value




							Robert Kammer

0
0




							Mark Baum

0
0




							Andrew Boll

0
0




							Clayton Edwards

0
0




							John Saharek

0
0




							Stephen Austin

0
0




							Richard Lindstrom

0
0




							Anthony Principi

0
0









					Insider Trading












Name
Shares Traded
Price


Kammer (Robert J)
10,000
$3.05


Lindstrom (Richard L)
100,000
$1.79


Kammer (Robert J)
20,000
$0.00


Baum (Mark L)
200,000
$1.72


Lindstrom (Richard L)
100,000
$1.79


Baum (Mark L)
83,709
$1.72


Baum (Mark L)
156,000
$1.79


Boll (Andrew R)
39,000
$1.79


Kammer (Robert J)
95,000
$4.58


Opaleye Management Inc.
45,000
$3.65


Boll (Andrew R)
15,000
$3.68


Principi (Anthony J)
4,573
$0.00


Lindstrom (Richard L)
4,469
$0.00




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research























Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft






















Loading Your Search Results - PeopleLooker.com























Updating Data On {{nameize fn}}{{#if mi}} {{nameize mi}}{{/if}} {{nameize ln}} {{#validLocation city}}in {{city}}{{#validLocation state}},{{/validLocation}} {{/validLocation}}{{#validLocation state}}{{#unless city}}in {{/unless}}{{uppercase state}}{{/validLocation}}
Important! PeopleLooker uses real public records. The information may be surprising.












Less than 30 seconds remaining


Continue to Results 







Now
We look up all people named {{nameize fn}} {{nameize ln}}.




Next
You pick which one you're looking for.




Then
We search our database for info on them.




Hooray!
You get your report!












Where does {{nameize fn}}{{#if mi}} {{uppercase mi}}{{/if}} {{nameize ln}}
live?
Please help us narrow down your search











All States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming





I'm not sure














Please enter a full name
Please help us narrow down your search







First Name:

Please Enter First Name


Last Name:

Please Enter Last Name












































People Searching Made Easy! | PeopleLooker
































Looking to Find Out About Someone?

Find information you may not get on Google.












State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming





Search





We respect your privacy.













We've run over


1,000,000


background reports!
Successful background reports!









Access Premium Public Records

Quickly search public records that could otherwise take you weeks or months
to collect. Find friends, relatives, neighbors, or even yourself. Comprehensive
people search reports may contain:




Names
Criminal Records
Date of Birth




Phone Numbers
Addresses
Court Records




Relatives
Email Addresses
Much More!




Names
Criminal Records
Date of Birth
Relatives
Email Addresses




Phone Numbers
Addresses
Court Records
Much More!







The New Way to Find People
More than a regular search engine.

It's the quick and easy way to look people up. Do a deep public record
search to uncover the important information you're looking for. Now you'll
never have to search someone on google again.





































People Searching Made Easy! | PeopleLooker
































Looking to Find Out About Someone?

Find information you may not get on Google.












State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming





Search





We respect your privacy.













We've run over


1,000,000


background reports!
Successful background reports!









Access Premium Public Records

Quickly search public records that could otherwise take you weeks or months
to collect. Find friends, relatives, neighbors, or even yourself. Comprehensive
people search reports may contain:




Names
Criminal Records
Date of Birth




Phone Numbers
Addresses
Court Records




Relatives
Email Addresses
Much More!




Names
Criminal Records
Date of Birth
Relatives
Email Addresses




Phone Numbers
Addresses
Court Records
Much More!







The New Way to Find People
More than a regular search engine.

It's the quick and easy way to look people up. Do a deep public record
search to uncover the important information you're looking for. Now you'll
never have to search someone on google again.





































People Searching Made Easy! | PeopleLooker
































Looking to Find Out About Someone?

Find information you may not get on Google.












State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming





Search





We respect your privacy.













We've run over


1,000,000


background reports!
Successful background reports!









Access Premium Public Records

Quickly search public records that could otherwise take you weeks or months
to collect. Find friends, relatives, neighbors, or even yourself. Comprehensive
people search reports may contain:




Names
Criminal Records
Date of Birth




Phone Numbers
Addresses
Court Records




Relatives
Email Addresses
Much More!




Names
Criminal Records
Date of Birth
Relatives
Email Addresses




Phone Numbers
Addresses
Court Records
Much More!







The New Way to Find People
More than a regular search engine.

It's the quick and easy way to look people up. Do a deep public record
search to uncover the important information you're looking for. Now you'll
never have to search someone on google again.





































People Searching Made Easy! | PeopleLooker
































Looking to Find Out About Someone?

Find information you may not get on Google.












State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming





Search





We respect your privacy.













We've run over


1,000,000


background reports!
Successful background reports!









Access Premium Public Records

Quickly search public records that could otherwise take you weeks or months
to collect. Find friends, relatives, neighbors, or even yourself. Comprehensive
people search reports may contain:




Names
Criminal Records
Date of Birth




Phone Numbers
Addresses
Court Records




Relatives
Email Addresses
Much More!




Names
Criminal Records
Date of Birth
Relatives
Email Addresses




Phone Numbers
Addresses
Court Records
Much More!







The New Way to Find People
More than a regular search engine.

It's the quick and easy way to look people up. Do a deep public record
search to uncover the important information you're looking for. Now you'll
never have to search someone on google again.



























Background Checks and Public Records Search - Truthfinder








 


















Call Toll Free!  (800) 699-8081



Public Records Search
Social Media, Photos, Police Records, Background Checks, Contact Information and Much More!









START HERE - Try searching a friend, relative, celebrity, yourself, or someone else you might know...



First Name:





Last Name:





City:





State:


All States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
District Of Columbia
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virgin Islands
Virginia
Washington
West Virginia
Wisconsin
Wyoming





This is me
Searching for yourself?




Search





  This secure connection is confirmed




We're Very Popular















What Our Happy Users Are Saying




"TruthFinder.com is freakishly accurate… Really scary how much info is out there." -Zac K.


"You found an old friend for me. Thank you." -Nancy V.


"TruthFinder is an excellent site for finding out about someone." -Sherrie F.


"This site is so wonderful. I found my lost godchildren and their mom. Thank you so much." -Lawrence W.


"This is one way to really know a potential date." -Charmaine R.


"Your service is more than perfect. It is a blessing. Thank you for the very hard work that you do." -Richard B.


"Truthfinder is a very accurate updated system. Their information is proper. And can be very helpful too." -Juan M.









Notice
This site contains REAL police records (court records of driving citations, speeding tickets, felonies, misdemeanors, sexual offenses, mugshots, etc.), background reports, photos, court documents, address information, phone numbers, and much more. Please BE CAREFUL when conducting a search and ensure all the information you enter is accurate.
Learning the truth about the history of your family and friends can be shocking, so please be cautious when using this tool.
TruthFinder does not provide consumer reports and is not a consumer reporting agency. We provide a lot of sensitive information that can be used to satisfy your curiosity, protect your family, and find the truth about the people in your life. You may not use our service or the information it provides to make decisions about consumer credit, employers, insurance, tenant screening, or any other purposes that would require FCRA compliance.
I Understand


Help Us Refine Your Results
Select Your Gender



Male



Female

NEXT

Skip
















